Alzheimer's Disease - Pipeline Review, H2 2015 - Research and Markets

Research and Markets (http://www.researchandmarkets.com/research/d6f3nh/alzheimers) has announced the addition of the "Alzheimer's Disease - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Alzheimer's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alzheimer's Disease and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Alzheimer's Disease Overview
3. Therapeutics Development
4. Pipeline Products for Alzheimer's Disease - Overview
5. Pipeline Products for Alzheimer's Disease - Comparative Analysis
6. Alzheimer's Disease - Therapeutics under Development by Companies
7. Alzheimer's Disease - Therapeutics under Investigation by Universities/Institutes
8. Alzheimer's Disease - Pipeline Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Alzheimer's Disease - Products under Development by Companies
13. Alzheimer's Disease - Products under Investigation by Universities/Institutes
14. Alzheimer's Disease - Companies Involved in Therapeutics Development (Partial List)
    

• AB Science SA
• AbbVie Inc.
• AC Immune SA
• Acelot, Inc.
• Actinogen Limited
• Acumen Pharmaceuticals, Inc.
• Addex Therapeutics Ltd
• Aequus Pharmaceuticals Inc.
• AFFiRiS AG
• Alector LLC
• Alkermes Plc
• ALSP, Inc.
• Alzhyme Pty Ltd
• Alzinova AB
• AlzProtect SAS
• Amarantus Bioscience Holdings, Inc.
• Amgen Inc.
• Anavex Life Sciences Corp.
• Aphios Corporation
• Apodemus AB
• Applied Research using OMIC Sciences, S.L.
• Araclon Biotech, S.L.
• Archer Pharmaceuticals, Inc.
• ArmaGen,Inc.
• Artery Therapeutics, Inc.
• AskAt Inc.
• Astellas Pharma Inc.
• AstraZeneca Plc
• Asubio Pharma Co., Ltd.
• Ausio Pharmaceuticals, LLC
• Avergen Ltd
• Avineuro Pharmaceuticals, Inc.
• Axerion Therapeutics, Inc.
• Axon Neuroscience SE
• Axovant Sciences Ltd.
  

For more information visit http://www.researchandmarkets.com/research/d6f3nh/alzheimers

View source version on businesswire.com: http://www.businesswire.com/news/home/20160208006095/en/